2017 ABSTRACT SUBMISSION INFORMATION

Poster Guidelines:
Poster presenters will have one half of a standard horizontal North American poster board. Poster should be no larger than 45" x 45" (115cm X 115m) and can be attached to the board with push pins (supplied onsite) or Velcro. Additional instructions, including submitting your poster in an electronic format, have been sent to the presenting author.

Embargo information:
The embargo for abstracts published in the 2017 abstract supplement to SNO official journal Neuro-Oncology will lift at 7:00 AM (EST) on Monday, November 6, 2017. These abstracts will be made available at: https://academic.oup.com/neuro-oncology. The embargo for accepted Late-Breaking abstracts will lift at 7:00 AM (EST) on the first day of the scientific meeting, Friday, November 17, 2017.  These abstracts will be made available at: https://academic.oup.com/neuro-oncology.



Abstract deadline has passed
.
Abstracts for the 2017 Society for Neuro-Oncology Annual Meeting are now being accepted. As you prepare to submit your abstract, please note:

  • The abstract deadline is June 12, 2017, 11:59pm CST
  • Abstracts are limited to 300 words; figures and tables are not allowed
  • Abstract titles should use sentence case (i.e., only the first letter of the title should be capitalized)
  • The body of the abstract should be in a single paragraph. If subheaders are used, they should be within that single paragraph in all-caps, not bolded (e.g., METHODS:)
  • Abstracts should be data-driven and must include this information in the body of the abstract
  • The embargo for abstracts published in the 2017 abstract supplement to SNO official journal Neuro-Oncology will lift at 7:00 AM (EST) on Monday, November 6, 2017. These abstracts will be made available at: https://academic.oup.com/neuro-oncology
  • For information and special guidelines on Late-Breaking Abstracts,  click here.

 


Abstracts will be accepted in the following categories:

BASIC SCIENCE ABSTRACT CATEGORIES

  • Angiogenesis and Invasion
  • Cell Biology
  • Cell Signaling and Signaling Pathways
  • Drug Discovery
  • Drug Resistance
  • Experimental Therapeutics-non-immunological
  • Genetics and Epigenetics
  • Immunology
  • Metabolomics
  • Pediatric Tumors-non-immunological
  • Radiobiology
  • Stem Cells
  • Tumor Microenvironment
  • Tumor Models

CLINICAL ABSTRACT CATEGORIES

  • Adult Clinical Trials-Immunologic
  • Adult Clinical Trials-non-Immunologic
  • CNS Metastasis
  • Epidemiology
  • Meningioma
  • Health Outcome Measures
  • Molecular Pathology and Classification-Adult and Pediatric
  • Neuro-Cognitive Outcomes
  • Neuroimaging
  • Neurological Complications of Cancer
  • Neurotoxicity of Cancer Treatment
  • Pediatric Clinical Trials and Outcomes
  • Quality of Life

Latest News

First EANO-SNO Brain Tumor Club

Wednesday, October 10, 2018

Call For Abstracts - SNO 2018 Annual Meeting

Submission Deadline June 4, 2018, 11:59pm CST

SNO Online Education Center

View select presentations from the 2017 Annual Meeting

3rd CNS Anticancer Drug Discovery and Development Conference

November 14 - 15, 2018, immediately preceding the 2018 SNO Meeting. Abstracts now being accepted.

ISPNO 2018, June 30 - July 3, 2018, Denver, CO

Register now at www.ispno2018.com